AzTrials
AzTrials

ShameEMBER-2NCT07235722

How a Resilience-Focused Intervention is Perceived by Women Subjected to Domestic Violence

An observational study of Shame and Intimate Partner Violence, run by Uppsala University at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

At Uppsala University Hospital, there is an outpatient clinic for women subjected to intimate partner violence. In order to explore how patients experience the biopsychosocial resilience-based intervention in use at the clinic and how well the intervention fits the needs of the patients, 30 patients from different… Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Qualitative interview
How many people
30 participants
Where
1 siteSweden
Study dates
7 Apr 2026to Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: The participants are patients at the NCK outpatient clinic at Uppsala University Hospital, due to experiences of being subjected to intimate partner violence. Due to clinic admission criteria, the population is limited to women over 18 of age. Participants are enrolled by strategic sampling to assure a diverse sample across variables of health, age, ethnicity, socio-economy and time enrolled at the clinic.

Who may be able to join

  • Enrolled in the EMBER intervention at the NCK outpatient clinic.

Who cannot join

  • Any situation that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Tove Filén, PhD-student contact

+46721476848

tove.filen@nck.uu.se

Sweden1 site, 1 recruiting
  • Uppsala University Hospital

    Uppsala, Uppsala County, 75185

    Recruiting

Other trials in Sweden

About this study

Official title: Exploring Resilience. A Qualitative Study of an Intervention After Intimate Partner Violence.

At Uppsala University Hospital, there is an outpatient clinic for women subjected to intimate partner violence. In order to explore how patients experience the biopsychosocial resilience-based intervention in use at the clinic and how well the intervention fits the needs of the patients, 30 patients from different stages of their contact at the clinic and with diverse life situations and background are enrolled. The researchers will carry out individual in-person interviews, each lasting approximately 60 minutes, based on a semi-structured set of questions. The questions concern the participant´s life situation, resilience and self-perceived needs, how well the intervention has met those needs and how it was perceived by the participant. The interviews are audio-recorded and transcribed verbatim for thematic analysis.

Being tested
Qualitative interview
Keywords
Qualitative, interview, Intimate Partner Violence, Domestic Violence, domestic violence exposure, gender-based violence, Shame, Resilience, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Qualitative interviewBehavioural

    A semi-structured interview

Study groups in NCT07235722
Study groupRoleWhat they receive
EMBER-intervention participantsWomen subjected to intimate partner violence at the NCK outpatient clinic
Receives: Behavioral: Qualitative interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient experiences of EMBER

    Interview questions exploring experiences and attitudes regarding the EMBER intervention

    Measured: To be conducted at the time of enrollment

Secondary outcomes (1)
  1. Needs and resilience

    Interview questions concerning perceptions and beliefs regarding what is needed for recovery after intimate partner violence

    Measured: to be conducted at the time of enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2025
  2. Study start7 Apr 2026
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07235722
Sponsor's protocol ID
EMBER-2
Other IDs
2025-04335-01, 2025
Acronym
EMBER-2
Status last verified
Apr 2026
First submitted
14 Nov 2025
Last updated
13 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Shame and Intimate Partner Violence, run by Uppsala University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tove Filén, PhD-student (+46721476848, tove.filen@nck.uu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient experiences of EMBER (time frame: To be conducted at the time of enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in